We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
Cap. Flow
-$880M
Cap. Flow %
-3.82%
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$63.2M
2
EXP icon
Eagle Materials
EXP
+$56.2M
3
ITRI icon
Itron
ITRI
+$54.4M
4
AAPL icon
Apple
AAPL
+$52.6M
5
ENPH icon
Enphase Energy
ENPH
+$40.6M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$82.8M
2
NVDA icon
NVIDIA
NVDA
+$76M
3
MSFT icon
Microsoft
MSFT
+$62.6M
4
ADBE icon
Adobe
ADBE
+$62.2M
5
JBL icon
Jabil
JBL
+$41M

Sector Composition

Rank Sector Weight
1 Technology 36.79%
2 Healthcare 19.28%
3 Financials 10.14%
4 Communication Services 9.05%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MODN
1601
DELISTED
MODEL N, INC.
MODN
-136,500
Closed -$3.89M
SWAV
1602
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-63,300
Closed -$20.6M
ALPN
1603
DELISTED
Alpine Immune Sciences Inc
ALPN
-102,000
Closed -$4.04M
DOOR
1604
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
-3,844
Closed -$505K
AEL
1605
DELISTED
American Equity Investment Life Holding Company
AEL
-12,667
Closed -$712K
MDC
1606
DELISTED
M.D.C. Holdings, Inc.
MDC
-11,743
Closed -$739K

Similar funds

Handelsbanken Fonder's Q2 2024 Portfolio in Review

As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.

  • Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
  • Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
  • Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
  • Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
  • Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
  • Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
  • Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.

Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.